Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
14.90
Dollar change
+0.35
Percentage change
2.41
%
IndexRUT P/E- EPS (ttm)-2.75 Insider Own12.44% Shs Outstand59.92M Perf Week-1.72%
Market Cap897.58M Forward P/E- EPS next Y-3.54 Insider Trans-0.80% Shs Float52.74M Perf Month-10.35%
Income-161.34M PEG- EPS next Q-0.77 Inst Own100.23% Short Float13.28% Perf Quarter-22.19%
Sales1.58M P/S568.09 EPS this Y-19.40% Inst Trans36.14% Short Ratio16.88 Perf Half Y-10.02%
Book/sh7.90 P/B1.89 EPS next Y-7.78% ROA-37.40% Short Interest7.00M Perf Year-43.37%
Cash/sh8.20 P/C1.82 EPS next 5Y- ROE-41.00% 52W Range12.60 - 30.85 Perf YTD-17.73%
Dividend Est.- P/FCF- EPS past 5Y-22.68% ROI-33.36% 52W High-51.70% Beta1.12
Dividend TTM- Quick Ratio17.72 Sales past 5Y-32.88% Gross Margin-132.53% 52W Low18.21% ATR (14)0.84
Dividend Ex-Date- Current Ratio17.72 EPS Y/Y TTM7.43% Oper. Margin-11654.75% RSI (14)45.87 Volatility5.30% 5.78%
Employees158 Debt/Eq0.02 Sales Y/Y TTM-83.69% Profit Margin-10211.14% Recom1.00 Target Price43.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q4.52% Payout- Rel Volume0.69 Prev Close14.55
Sales Surprise-100.00% EPS Surprise15.18% Sales Q/Q-100.00% EarningsFeb 27 AMC Avg Volume414.95K Price14.90
SMA20-2.00% SMA50-8.11% SMA200-10.71% Trades Volume286,456 Change2.41%
Date Action Analyst Rating Change Price Target Change
Dec-08-23Initiated Wells Fargo Overweight $41
May-18-23Initiated Canaccord Genuity Buy $48
Apr-13-23Initiated Robert W. Baird Outperform $44
Dec-14-22Initiated Stifel Buy $33
Dec-07-22Initiated JP Morgan Overweight $42
Sep-01-22Initiated Citigroup Buy $36
Jul-20-22Initiated SVB Leerink Outperform $33
May-25-22Initiated Cantor Fitzgerald Overweight $28
Dec-10-21Initiated Oppenheimer Outperform $40
Nov-24-21Initiated RBC Capital Mkts Outperform $38
Mar-27-24 10:23AM
Mar-12-24 07:30AM
Mar-07-24 10:00AM
Feb-27-24 04:03PM
Feb-26-24 08:00AM
08:00AM Loading…
Feb-07-24 08:00AM
Feb-04-24 03:29PM
Jan-19-24 08:28PM
Jan-03-24 08:00AM
Nov-13-23 04:30PM
Nov-09-23 04:05PM
08:44AM
Nov-08-23 08:00AM
Nov-07-23 10:00AM
Nov-06-23 08:00AM
04:03PM Loading…
Oct-31-23 04:03PM
Oct-19-23 08:00AM
Oct-16-23 04:05PM
Sep-28-23 09:58AM
Sep-27-23 10:52AM
09:01AM
Sep-26-23 02:26PM
12:10PM
07:30AM
Sep-25-23 04:05PM
Sep-15-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 08:00AM
Aug-28-23 04:05PM
10:22AM
05:15PM Loading…
Aug-09-23 05:15PM
04:03PM
08:00AM
Jul-28-23 03:57PM
Jul-25-23 08:00AM
Jun-23-23 07:30AM
Jun-05-23 08:02PM
06:19AM
May-24-23 08:00AM
May-18-23 01:50PM
May-10-23 08:05AM
May-09-23 05:45PM
04:02PM
May-04-23 06:25PM
Apr-30-23 02:10PM
Apr-12-23 08:01AM
Apr-09-23 01:19PM
Mar-27-23 08:01AM
Mar-13-23 08:01AM
Mar-11-23 07:29AM
Mar-09-23 06:15PM
04:05PM
Mar-08-23 04:01PM
Mar-05-23 07:55AM
Mar-01-23 08:01AM
Feb-24-23 01:03PM
Feb-07-23 08:01AM
Feb-02-23 08:02AM
07:45AM
Jan-27-23 04:03PM
Jan-26-23 04:16PM
Jan-25-23 10:21AM
08:01AM
Jan-24-23 09:19PM
Jan-23-23 04:11PM
04:01PM
08:59AM
07:49AM
06:16AM
Jan-22-23 02:00PM
Jan-12-23 04:55AM
Jan-03-23 08:00AM
Dec-25-22 07:39AM
Dec-15-22 08:00AM
Dec-08-22 09:38AM
Nov-15-22 08:00AM
Nov-08-22 05:15PM
04:02PM
Oct-25-22 09:40AM
Oct-19-22 12:02PM
Oct-05-22 08:00AM
Sep-26-22 07:01AM
Sep-15-22 09:39AM
08:00AM
Sep-09-22 01:42PM
Sep-07-22 10:12AM
Sep-06-22 09:40AM
Sep-05-22 12:00PM
Sep-02-22 12:29PM
Sep-01-22 09:55AM
08:00AM
Aug-30-22 08:00AM
Aug-16-22 08:26AM
Aug-15-22 09:55AM
Aug-10-22 08:19AM
Aug-09-22 07:40AM
Aug-08-22 05:25PM
04:05PM
Aug-05-22 11:55AM
Aug-04-22 01:43PM
Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coulie BernardPresident and CEOJan 17 '24Sale17.2325,721443,173316,382Jan 19 05:19 PM
Lefebvre EricChief Medical OfficerJan 17 '24Sale17.2310,295177,383156,920Jan 19 05:18 PM
Hull HansChief Business OfficerJan 17 '24Sale17.239,786168,613185,069Jan 19 05:19 PM
Cummings Keith LamontChief Financial OfficerJan 17 '24Sale17.239,781168,527194,605Jan 19 05:19 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yJan 17 '24Sale17.235,19789,54455,246Jan 19 05:11 PM
Hull HansChief Business OfficerAug 04 '23Option Exercise2.088,79118,285214,905Aug 07 08:50 PM
Hull HansChief Business OfficerAug 04 '23Sale20.0120,050401,201194,855Aug 07 08:50 PM
Hull HansChief Business OfficerAug 03 '23Option Exercise2.081,8003,744207,914Aug 07 08:50 PM
Hull HansChief Business OfficerAug 03 '23Sale20.0013,069261,380206,114Aug 07 08:50 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yJul 20 '23Sale17.554,75583,45060,443Jul 21 04:40 PM
Coulie BernardPresident and CEOJul 17 '23Sale18.0170,1501,263,338342,103Jul 19 08:20 PM
Lefebvre EricChief Medical OfficerJul 17 '23Sale18.0122,321401,981167,215Jul 19 08:29 PM
Cummings Keith LamontChief Financial OfficerJul 17 '23Sale18.0119,771356,058203,999Jul 19 08:23 PM
Hull HansChief Business OfficerJul 17 '23Sale18.0117,937323,029219,183Jul 19 08:26 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yJul 17 '23Sale18.0112,778230,12065,198Jul 19 08:31 PM
Cummings Keith LamontChief Financial OfficerJun 13 '23Option Exercise2.0830,75063,960185,020Jun 14 06:14 PM
Cummings Keith LamontChief Financial OfficerJun 09 '23Option Exercise2.085,80012,064154,270Jun 12 06:19 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yApr 03 '23Sale26.792,87777,06650,789Apr 03 07:07 PM
Coulie BernardPresident and CEOMar 30 '23Sale26.5235,339937,222274,753Apr 03 06:46 PM
Lefebvre EricChief Medical OfficerMar 30 '23Sale26.5211,245298,228145,786Apr 03 07:01 PM
Cummings Keith LamontChief Financial OfficerMar 30 '23Sale26.529,960264,148148,470Apr 03 06:48 PM
Hull HansChief Business OfficerMar 30 '23Sale26.529,036239,643201,964Apr 03 06:51 PM
Ouimette MikeGeneral Counsel & Corp. Sec'yMar 30 '23Sale26.524,874129,26353,666Apr 03 07:07 PM